Predictors of genetic testing uptake in newly diagnosed breast cancer patients

Background and Objectives Many newly diagnosed breast cancer patients do not receive genetic counseling and testing at the time of diagnosis. We examined predictors of genetic testing (GT) in this population. Methods Within a randomized controlled trial of proactive rapid genetic counseling and testing vs usual care, patients completed a baseline survey within 6 weeks of breast cancer diagnosis but before a definitive survey. We conducted a multinomial logistic regression to identify predictors of GT timing/uptake. Results Having discussed GT with a surgeon was a dominant predictor (χ2 (2, N = 320) = 70.13; P